EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer

Hong Liu, Jing Wang, Yunhai Li, Feng Luo iD, Lei Xing iD

The Breast Journal · 2024

DOI: 10.1155/2024/2981722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Breast Journal, 2024. Verfasst von Hong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Rd, Chongqing 400016, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Up-Regulation, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of this study was to analyze SUMO activating enzyme subunit 1 (SAE1) expression in breast cancer (BC). Through bioinformatics analysis and in vitro experiments, the biological function and possibly associated signal pathways of SAE1 in BC were further analyzed.

Methods

Bioinformatics analysis was applied to analyze SAE1 expression in BC and normal breast tissues, its relationship with clinicopathologic characteristics and prognosis in BC patients, and data from the Cancer Genome Atlas database and Gene Expression Omnibus dataset. We performed immunohistochemistry to analyze SAE1 expression in BC tissues and para‐cancer tissues in 79 breast cancer patients. BC cell proliferation was detected with the Cell Counting Kit‐8 and by the colony formation assay. Cell cycle progression was analyzed by flow cytometry, and the expression of cell cycle‐related proteins (E2F1, cyclin D3, and cyclin‐dependent kinase 2) was determined by western blots in SAE1 small interfering RNA (siRNA) transfected cells. The GSE1456 dataset was used to analyze possible signal pathways associated with SAE1 by gene set enrichment analysis (GSEA), and the expression of PI3K/AKT/mTOR pathway‐related proteins (such as p‐PI3K, p‐AKT, and mTOR) in SAE1‐siRNA cells was detected by western blots.

Results

The bioinformatics and immunohistochemical results showed that SAE1 mRNA and protein expression in BC tissues were significantly higher than those in normal tissues. The SAE1 overexpression was significantly associated with the tumor size, tumor‐node‐metastasis stage, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and whether or not it was a triple‐negative BC. Patients with SAE1 overexpression had a worse overall survival (OS), recurrence‐free survival (RFS), and distant metastasis‐free survival compared with lower expression patients. Multivariate Cox regression analysis showed that SAE1 may be an independent prognostic factor for OS of BC patients. The proliferation and cell cycle process of BC cells were inhibited by SAE1‐siRNA in vitro. The result of GSEA showed that SAE1 was significantly associated with 12 gene sets, including unfolded protein reaction, DNA repair, oxidative phosphorylation, and cell cycle, among others. Additionally, two signal pathways, mTORC1 and PI3K/Akt/mTOR, were significantly correlated with SAE1 overexpression. Western blots confirmed that the expression of PI3K/Akt/mTOR pathway‐related proteins (p‐PI3K, p‐AKT, and mTOR) in BC cells was decreased after knocking down SAE1.

Conclusion

SAE1 was highly expressed in BC. Its overexpression was associated with poor BC prognosis. Additionally, it was an independent prognostic factor for BC patients. We demonstrated that in vitro SAE1 knockdown effectively inhibited BC proliferation and its cell cycle process. Furthermore, the biological function of SAE1 may be associated with the PI3K/Akt/mTOR pathway. SAE1 will be a potential target for BC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsUp-RegulationCell ProliferationHumansFemalePrognosisMiddle AgedProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesSignal TransductionUbiquitin-Activating EnzymesPhosphatidylinositol 3-KinasesGene Expression Regulation, NeoplasticCarcinogenesisCell Line, Tumor

Substanzen

Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesUbiquitin-Activating EnzymesPhosphatidylinositol 3-KinasesMTOR protein, human

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Rd, Chongqing 400016, China.
  • Chongqing Key Laboratory of Molecular Oncology and Epigenetics The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Rd, Chongqing 400016, China.
  • Department of Head Neck and Breast Surgery The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China, Hefei 230031, Anhui, China.
  • Department of Head Neck and Breast Surgery Anhui Provincial Cancer Hospital, Hefei 230031, Anhui, China.

ORCID-Profile: Feng Luo, Lei Xing

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Liu, H., Wang, J., Li, Y., Luo, F., & Xing, L. (2024). Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer. The Breast Journal. https://doi.org/10.1155/2024/2981722

Vancouver

Liu H, Wang J, Li Y, Luo F, Xing L. Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer. The Breast Journal. 2024. doi:10.1155/2024/2981722

BibTeX
@article{Liu2024,
  author = {Liu, Hong and Wang, Jing and Li, Yunhai and Luo, Feng and Xing, Lei},
  title = {Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer},
  journal = {The Breast Journal},
  year = {2024},
  doi = {10.1155/2024/2981722}
}
Kostenlos starten →